FOLH1 and metastatic prostate carcinoma: The prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein of the prostate secretory acinar epithelium, is known from its widely adopted use in diagnostics for metastatic prostate carcinoma using 68Ga-PSMA-PET/CT [9].